BioWorld - Wednesday, March 18, 2026

BioWorld Science

Aug. 14, 2020

View Archived Issues

Starving out Chlamydia

Read More

First-in-human study of KCP-506 approved in Netherlands

Read More

Nirsevimab prevents RSV-associated lower respiratory tract infections in preterm infants

Read More

Multiple sclerosis drug prevents HIV infection in vitro

Read More

Applied StemCell receives NIH grant to advance its TARGATT technology

Read More

Prometheus and Falk enter global collaboration agreement to develop and commercialize PR-600

Read More

Minghui Pharmaceutical discovers nucleoside derivatives

Read More

New MNK1 and MNK2 inhibitors identified at Novostar Pharmaceuticals

Read More

Jiangsu Hansoh Pharmaceutical Group, Shanghai Hansoh Biomedical patent JAK-2, TYK2 inhibitors

Read More

SCO-267 improves liver parameters in a mouse model of NAFLD

Read More

Exelixis synthesizes new AXL and/or MERTK inhibitors

Read More

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents AKT inhibitors

Read More

New PTP-2C inhibitors disclosed by Betta Pharmaceuticals

Read More

Theralase re-initiates phase II study of TLD-1433 in Canada

Read More

Healx enters a new partnership to accelerate development of therapeutics for Angelman Syndrome

Read More

First patient recruited in phase II study of ASN-002 in combination with vismodegib

Read More

Clinical improvement seen with anti-MASP-2 monoclonal antibody narsoplimab in COVID-19 patients

Read More

Debiopharm presents 3-year follow-up data from phase II study of Debio-1143

Read More

Ad26.COV2.S vaccine provides robust protection against SARS-CoV-2 in rhesus macaques

Read More